نمایش پرونده ساده آیتم

dc.contributor.authorPouyafar, A
dc.contributor.authorHeydarabad, MZ
dc.contributor.authorMahboob, S
dc.contributor.authorMokhtarzadeh, A
dc.contributor.authorRahbarghazi, R
dc.date.accessioned2018-08-26T07:11:51Z
dc.date.available2018-08-26T07:11:51Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44494
dc.description.abstractA multitude of clinical studies showed the elevation of YKL-40 in subjects with different kinds of tumors. It is predicted that an inherent correlation exists between survivals of cancer patients with total YKL-40 serum levels, making this factor as a potential novel biomarker. However, the crucial role of YKL-40 in the dynamics of cancers, especially angiogenesis, has not yet been completely addressed. In this review, we highlighted the various facets of YKL-40 and its importance in cancer biology as a bio-shuttle in gene therapy.
dc.language.isoEnglish
dc.relation.ispartofBIOMEDICINE & PHARMACOTHERAPY
dc.subjectCancer biology
dc.subjectAngiogenesis
dc.subjectYKL-40 factor
dc.titleAngiogenic potential of YKL-40 in the dynamics of tumor niche
dc.typeArticle
dc.citation.volume100
dc.citation.spage478
dc.citation.epage485
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.biopha.2018.02.050


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم